By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Avidia, Inc. 

2450 Bayshore Parkway, 2nd Floor

Mountain View  California  94043  U.S.A.
Phone: 650-404-2000 Fax:


SEARCH JOBS


Industry
Biotechnology


Collaborations

MedImmune 





Company News
Maxygen, Inc. (MAXY) To Receive $17.8 Million From Acquisition Of Avidia, Inc. By Amgen (AMGN) 10/27/2006 5:38:11 PM
Amgen (AMGN) Completes Acquisition Of Avidia, Inc. 10/25/2006 11:58:56 AM
The Day In Review: Amgen (AMGN) Buys Avidia, Inc. For $290 Million 10/3/2006 10:23:09 AM
Amgen (AMGN) To Acquire Avidia, Inc., A Privately Held Biopharmaceutical Company In The San Francisco Bay Area; $290 Million Cash 9/29/2006 9:57:59 AM
Avidia, Inc. Initiates Clinical Trial Of Novel Inhibitor Of Interleukin-6 For Crohn's Disease 9/20/2006 11:28:54 AM
Avidia, Inc. Adds Dr. Jose-Carlos Gutierrez-Ramos To Its Management Team As Chief Scientific Officer 8/29/2006 1:28:25 PM
Avidia, Inc. Expands Senior Management Team 6/27/2006 11:48:21 AM
Avidia, Inc. Raises $43.8M Series C To Advance New Class Of Pharmaceuticals 5/9/2006 12:24:35 PM
The Journal Nature Biotechnology Publishes An Article Describing Avidia, Inc.'s Avimer Technology 11/7/2005 1:01:57 PM
MedImmune, Inc. (MEDI) Further Expands Oncology Pipeline With New Target Based On Innovative Technology From Avidia, Inc. 10/20/2005 2:37:31 PM
12
//-->